Concord Medical Services (NYSE:CCM) Share Price Passes Above Two Hundred Day Moving Average – What’s Next?

Concord Medical Services Holdings Limited (NYSE:CCM) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $5.15 and traded as high as $5.16. Concord Medical Services shares last traded at $4.80, with a volume of 47,760 shares.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Concord Medical Services in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

Concord Medical Services Stock Performance

The company has a debt-to-equity ratio of 1.32, a quick ratio of 0.41 and a current ratio of 0.42. The firm’s fifty day moving average price is $4.38 and its 200 day moving average price is $5.15.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.